About Michelson Diagnostics
A passion for healthier skin and happier lives
Our Mission
At Michelson Diagnostics, we are driven by
a singular purpose:
To empower clinicians and researchers with revolutionary skin imaging that improves skin health and enhances patient outcomes. Our advanced Optical Coherence Tomography (OCT) technology delivers high-resolution, real- time imaging beneath the skin’s surface — giving users The Whole Picture® of what’s happening below.
Who We Are
Michelson Diagnostics is based in Kent, in the South of the United Kingdom.
Founded in March 2006 by a team of physicists and engineers, it has pioneered the practical application of OCT in dermatology and skin research. Since then, our evolving VivoSight product line has been widely adopted by clinical users and research centres in Europe, USA, Asia and Australia. To date it has been used to perform over 200,000 patient scans, and has been cited in over 800 peer- reviewed publications, reflecting its scientific credentials and clinical impact.
We believe OCT skin imaging has transformative potential — helping clinicians make better, more informed decisions without invasive procedures, and enabling researchers to gain deeper insights into skin structure and pathology. Our purpose is to expand access to meaningful, cost-effective OCT solutions that support everyday clinical and research needs.
What We Do
Our next generation OCT system, VivoSight Dx Pro, delivers non-invasive, high-resolution 3D imaging of skin microstructure and vasculature.
It offers unmatched depth and field-of-view, helping dermatologists, clinicians, and research professionals visualize and quantify subtle changes beneath the skin’s surface that other imaging methods cannot reveal. The addition of artificial intelligence in VivoSight Dx Pro makes clinical diagnostic scanning easier and faster to use, making this truly accessible to every dermatologists.
In the USA, customer sales and service is managed through Michelson Diagnostics Inc, based in California; and we have a growing network of distributors, growing and supporting our clinical and research markets around the world.
Meet the Management Team
-
Jon Holmes
CEO & Co-Founder
Jon brings over 30 years of engineering expertise to steer Michelson Diagnostics’ vision and technology development. Before co-founding Michelson Diagnostics, Jon held leadership roles in biomedical engineering and has authored patents and publications in OCT.
-
Alison Day
Financial Controller, Operations Manager
With more than three decades of experience in accounting and operational management, Alison ensures the company’s financial strength, operational excellence, and quality delivery across functions.
Board of Directors
-
Kevin D’Silva
Chairman
-
Jon Holmes
Director
-
Xavier Yon
Non-Executive Director